FdaApplication
ANDA 216902
Identifiers
- fda_app_no: ANDA216902
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
| approval_date | 2024-12-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EDARAVONE | EDARAVONE | 30MG/100ML (0.3MG/ML) | SOLUTION;INTRAVENOUS |
1 product